ABSTRACT
INTRODUCTION
Rheumatoid arthritis (RA) is a chronic autoimmune disease typically characterized by inflammation of the joints and their lining or synovium ). RA chiefly affects joints and ultimately leads to joint tissue destruction. The symptoms of RA include deformed joints, pain and swelling. Therefore, early diagnosis and prevention of RA is important. However, precise causes of RA are not fully understood. Recent studies showed that the synovium in RA patients is more hypoxic than normal synovium and hypoxia-related signaling regulates pro-inflammatory pathways in RA (Akhavani et al. 2009; Gao et al. 2015) . Furthermore, oxygen pressure is decreased in the RA synovium compared with normal joints (Paleolog 2009 ).
Synovial hypoxia is a prominent feature of RA (Akhavani et al. 2009; Del Rey et al. 2010; Ryu et al. 2014) . Under hypoxic conditions, low oxygen levels are associated with expression of hypoxia-inducible factors (HIFs) and increased pro-inflammatory cytokines (Melillo 2011) . HIFs principally drive the cellular response under hypoxia, through interaction with hypoxia-responsive elements that leads to gene expression (Rankin & Giaccia 2008) . In particulars, HIFs are increased in RA-affected joints, HIFs increase inflammatory cell infiltration and inflammatory-mediated products such as p38 and nuclear factor-kappa B (NF-kB) (Konisti et al. 2012) .
Activated protein C (APC) results from conversion of protein C and has cytoprotective anti-inflammatory, anti-apoptotic, and anticoagulant activities (Danese et al. 2010; McKelvey et al. 2014; Minhas et al. 2010) . APC is triggered by the thrombin-thrombomodulin complex and appears on the endothelial cell surface Xue & Jackson 2015) . The presence of the APC-specific receptor endothelial protein C receptor (EPCR) augments conversion to APC . EPCR is expressed on the surface of cells including endothelial cells and leukocytes (Lee et al. 2013; Seol et al. 2011; Thiyagarajan et al. 2007) . EPCR is also expressed in other cells that have anti-inflammatory activity mediated by APC (Bouwens et al. 2013; Lee et al. 2013; Thiyagarajan et al. 2007; Xue et al. 2014) . The anti-inflammatory activity of APC is associated with decreased leucocyte recruitment and proinflammatory mediators (Esmon 2012; Minhas et al. 2010) . APC reduces inflammation by regulating p38 activity by activating protease-activated receptor-2 (PAR-2) (Julovi et al. 2011) . APC is elevated in RA synovial joints and fluids and co-localizes with matrix metalloproteinase (MMP)-2 in the lining layer (Buisson-Legendre et al. 2004; .
MMP-2 is a member of the MMPs. Among this subfamily, the gelatinase subfamily includes MMP-2 and MMP-9 (Sela-Passwell et al. 2010) . MMPs are key mediators of inflammation and RA (Bauvois 2012; Xue & Jackson 2015) . In addition, activation and expression of are stimulated by APCs in endothelial cells and fibroblasts (Lee et al. 2013) . Previous studies showed that MMP-9 is decreased by APC in the ischemic brain (Cheng et al. 2006) . Furthermore, APC inhibits MMP-9 expression and stimulates MMP-2 activation and expression in synovial fibroblasts from RA patients and normal adults (Jackson et al. 2009; . However, the effect of APC on RA and normal fibroblast cells under hypoxic conditions is not fully understood.
To understand how synovial cells and chondrocytes behave in different oxygen tensions deep in the cartilage and during joint diseases such as RA, we examined APC effects on normal and RA synovial fibroblasts under normoxic (21% O 2 ) and hypoxic (1% O 2 ) conditions. Exposure to normoxia and hypoxia showed that APC treatment decreased phosphorylation of p38 in hypoxic conditions. Our results indicated that APC exerted a protective effect on RA synovial fibroblasts by inhibiting pro-inflammatory p38 and NF-kB and increasing antiinflammatory MMP-2 under hypoxic conditions.
MATERIALS AND METHODS

ISOLATION AND TREATMENT OF CELLS
Human synovial fibroblasts were isolated from the synovial tissues of RA patients during joint replacement surgery according to American College of Rheumatology criteria (Arnett et al. 1988) . Tissues were minced and digested with 2 mg/mL collagenase (Sigma-Aldrich, St. Louis, MO, USA) in Dulbecco's modified Eagle medium (DMEM) containing 100 U/mL penicillin/streptomycin, 10 mmol/L HEPES (all from Gibco BRL/Life Technologies, Carlsbad, CA, USA) and 3.7 g/L NaHCO3 at 37°C for 3 h, followed by digestion with 0.25% trypsin and 0.02% ethylenediaminetetraacetic acid at 37°C for 30 min. Cells were cultured in DMEM containing 10% fetal bovine serum (ICN, Aurora, OH, USA) in 75 cm 2 flasks at 37°C in a humidified 5% CO 2 atmosphere. Synovial cells were exposed to recombinant APC (Xigris; Eli Lilly, Indianapolis, IN) (0.1, 1, 10 and 20 μg/mL) under normoxic (21%O 2 ) and hypoxic (1% O 2 ) conditions. Ethical approval was granted by the Royal North Shore Animal care and Ethics Committee and Northern Sydney Health Human Research Ethics Committee.
CELL PROLIFERATION ASSAYS
Cell proliferation assays were performed as described previously (Julovi et al. 2011) . Cells (2 × 10 3 cells/well) were seeded into 96-well microplates to a final volume of 200 μL and incubated for 4 h to allow cells to attach. After preincubation for 12 h, cells were treated with APC for 72 h in serum-free conditions under normoxic and hypoxic conditions. Cells were stained with 1 μg/mL crystal violet (Sigma-Aldrich) dissolved in phosphate buffered saline (PBS). Unbound dye was removed by washing with tap water. Bound crystal violet was solubilized with 0.1% sodium dodecyl sulfate (SDS) in PBS. Optical density of wells was determined at 550 nm wavelength. The results were expressed relative to control.
GELATINE ZYMOGRAPHY
In order to determine if APC directly activated gelatinases MMP-2 and MMP-9, cells were incubated with APC; 6-AQ (1 μg/mL), a specific inhibitor of NF-kB activation; or a p38 inhibitor (100 nM) for 72 h under normoxic and hypoxic conditions. MMP-2 activation in culture medium and cells was measured using gelatin zymography (Ruf 2004) . Culture supernatants and cell lysates were loaded onto 10% SDS gels containing 0.5 mg/mL gelatin. Relative levels of MMP-2 were semiquantified using the Gel-Pro Analyzer (Media Cybernetics, Bethesda, MD).
WESTERN BLOTS
Cells were washed three times with PBS before lysis buffer (0.15 M NaCl, 0.01 mM PMSF, 1% NP-40, 0.02 M Tris, 6 M urea/H2O) was added. Cell lysates were centrifuged at 10,000 × g for 15 min and total protein concentration was determined using BCA protein assay kits (Pierce Biotechnology, Rockford, IL, USA). Equal amounts of protein were separated by 8-15% SDS-polyacrylamide gel electrophoresis and Western blots were as previously described (Xue et al. 2005) . Primary antibodies were rabbit antihuman EPCR (Santa Cruz Biotechnology, Santa Cruz, CA, USA), mouse antihuman MMP-9 (ab137867, Abcam ® , UK) and MT1-MMP (Chemicon International, Inc., Temucula, CA, USA), rabbit antihuman phosphorylated p38 (Santa Cruz Biotechnology) or mouse anti human NF-kB (Chemicon). Antihuman beta-actin was included to correct for unequal loading.
IMMUNOFLUORESCENCE
Cells were cultured on gelatin (0.2% w/v)-coated fourchamber glass slides and incubated with APC before processing for immunofluorescent staining as previously described (Riewald et al. 2002) . Briefly, cells were fixed with cold acetone, blocked by 5% donkey serum in PBS and incubated with goat polyclonal antibody against proteaseactivated receptor (PAR)-1 or mouse monoclonal antibody against PAR-2 (Santa Cruz Biotechnology) overnight at 4ºC. After three washes with PBS, cells were incubated with antimouse IgG conjugated with Cy3 or antigoat IgG conjugated with fluorescein isothiocynate. Cells were washed with PBS and mounted in fluorescence medium. Cells were observed with an Eclispse 80i fluorescence microscope (Nikon Corporation, Tokyo, Japan).
HYPOXIC CONDITIONS
A hypoxic chamber was used to culture synovial fibroblasts at low oxygen tension (1% O 2 ). For normoxic conditions (21% O 2 ), synovial fibroblasts were incubated at 37ºC in a 95% humidified atmosphere with 5% CO 2 .
STATISTICAL ANALYSIS Statistical differences were analyzed using Student's t-test. ANOVA was used to compare means among three or more independent groups, followed by the Newman-Keuls post-hoc test. Results are displayed as mean ± standard deviation (SD).
RESULTS
APC INCREASES SYNOVIAL FIBROBLAST PROLIFERATION AND ACTIVATION OF MMP-2 UNDER HYPOXIA
In order to explore effects of APC under hypoxic conditions, we used normal synovial fibroblasts (NFb) and RA synovial fibroblasts (RAFb). We examined the effect of APC on cell proliferation under normoxia and hypoxia. In NFb cells, cell proliferation by APC treatments was increased under normoxic condition. Furthermore, cell proliferation of RAFb increased with APC under normoxic or hypoxic condition (Figure 1 ). When RAFb were treated with APC under hypoxic conditions, cell proliferation was increased (Figure 1(b) ). APC treatment induced MMP-2 activation and expression in NFb and RAFb under normoxic and hypoxic conditions. However, APC induction of MMP-2 activation in hypoxic conditions was lower than in normoxic conditions ( Figure 1 ).
MMP EXPRESSION REGULATED BY APC IS DIFFERENT UNDER NORMOXIC AND HYPOXIC CONDITIONS
We next examined APC-induced expression of MMPs MT1 and MMP-9 in NFb and RAFb under normoxic and hypoxic conditions. MMP-9 expression was decreased by APC in NFb and RAFb under normoxic conditions. MMP-9 was slightly decreased after APC treatment of NFb under hypoxic conditions. MT1 MMP expression was not affected (Figure  2(a) ). In RAFb under hypoxic conditions, MMP expression was similar to NFb under hypoxic conditions (Figure 2 ). MMP expression differed between normoxic and hypoxic conditions: Under hypoxic conditions, MMP expression was reduced relative to normoxic conditions.
HYPOXIA AUGMENTS APC-INDUCED INFLAMMATORY MEDIATORS IN SYNOVIAL FIBROBLASTS
We next investigated whether APC regulated inflammatorymediated products in NFb and RAFb under hypoxic conditions. We examined if APC regulated PAR-1 and PAR-2 in RAFb under hypoxic conditions. APC treatment increased PAR-1 and PAR-2 expression (Figure 3(a) ). Subsequently, we tested expression of inflammatory-mediated products with APC under hypoxic conditions (Figure 3 ). In NFb under normoxic conditions, EPCR expression increased with APC treatment. Under hypoxic conditions, EPCR expression did not change with APC (Figure 3(b) ). However, total EPCR expression was higher than in normoxic conditions. These experiments showed that under hypoxic conditions, APC treatment downregulated phosphorylated p38 and NF-kB expression (Figure 3 Under hypoxic conditions, p38 phosphorylation and NF-kB activation increased. These events were interdependent with inflammation. Thus, we tested the effect of APC on p38 and NF-kB under hypoxic conditions using the p38 inhibitor SB203580 and the NF-kB inhibitor 6-AQ. We tested the activation of MMP-2 by APC under hypoxic conditions and found that active MMP-2 increased in culture supernatants with APC treatment, whereas APC did not affect MMP-2 activation in cells (Figure 4(a) ). Similar results were observed with p38 or NF-kB inhibitor and APC treatment. We verified APC-related inflammatory mediator expression in RAFb under hypoxic conditions (Figure 4(b) ). Under hypoxic conditions, MMP-9 reduction by APC was blocked by NF-kB inhibition. The effect of APC on RAFb under hypoxic condition was blocked by p38 inhibition. These results indicated that the effect of APC was via a p38-related pathway in RAFb under hypoxic conditions.
DISCUSSION
RA is a type of arthritis and a chronic autoimmune disorder (Huber et al. 2006; ). RA-related research is progressing steadily, however, the anti-inflammatory effect of APC on RA under hypoxic conditions is not fully understood. Previous reports show that APC reduces synovial hyperplasia in RA by inhibiting inflammatory signaling (Julovi et al. 2013) . Our study focused on the effect of APC in hypoxic conditions. Our results showed that inflammatory signaling was downregulated by APC under hypoxic conditions. In these conditions, APC reduced p38 phosphorylation and NF-kB expression to inhibit inflammation. A previous study showed that under hypoxic conditions, p38 mitogen-activated protein kinase (p38MPAK) is essential for fibroblast proliferation and acts as a modulator of pro-inflammatory responses in rheumatological conditions (Mortimer et al. 2007) . Indeed, if protease-activated receptors (PARs) are activated, they signal via p38 to induce immune responses (Julovi et al. 2011; Riewald & Ruf 2005) . Thus, we expected that activation of p38 by APC under hypoxic conditions would be involved in the proliferation and anti-inflammatory response of RAFb. Our results were similar to our hypothesis (Figure 4(b) ). Previous studies on APC and cell proliferation show APC inhibits proliferation (Julovi et al. 2013) . However, our experiments showed that APC increased cell proliferation under normoxic and hypoxic conditions (Figure 1 ). These results confirmed previous studies . Of note, the change in MMPs with APC in normoxia was also observed in hypoxia. This evidence disproves that the anti-inflammatory effect of APC is reducing pain from RA by regulating MMP expression. In RAFb under hypoxic conditions, downregulation of MMP-9 by APC was stronger than normoxic conditions. APC activated MMP-2 in both normoxia and hypoxia (Figure 4) . These results were similar with both p38 and NF-kB inhibitors. These findings demonstrated that anti-inflammatory activity of APC was via p38 signaling in synovial fibroblasts under hypoxia. We also observed APC-induced protein expression. Under normoxic conditions, MMP-9 expression was reduced by APC. Similar results were observed in hypoxic conditions (Figure 4(b) ). However, in hypoxic conditions, reduced expression of MMP-9 by APC was blocked by p38 inhibition. In addition, inhibition of NF-kB increased MMP-9 expression compared to no APC treatment. Our most important finding was that APC inhibited inflammation via p38-related signaling in RAFb under hypoxic conditions.
CONCLUSION
In summary, our findings provide features of APC in RA under hypoxic conditions. Hypoxia enhanced expression of EPCR and the effect of APC on RAFb via inhibition of p38 phosphorylation.
